Enzymatic protein hydrolysates in human nutrition

Trends in Food Science and Technology

Volumn 11, Issue 7, 2000, Pages 254-262

  Clemente, Alfonso ^a,b  

^a INSTITUTO DE LA GRASA   (Spain)

^b JOHN INNES CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC LIVER DISEASE; DIETARY INTAKE; DISEASE CONTROL; FOOD ALLERGY; HUMAN NUTRITION; NUTRITIONAL VALUE; PHENYLKETONURIA; PROTEIN HYDROLYSATE; PROTEIN HYDROLYSIS; PROTEIN PRODUCTION;

ALLERGIES; ENZYMES; HYDROLYSIS; PATIENT MONITORING; PROTEINS; UREA;

HYDROLYSATES;

NUTRITION;

EID: 0035096518     PISSN: 09242244     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-2244(01)00007-3     Document Type: Article

References (82)

1. Medical food. A scientific status summary
2. Research needs in diet, nutrition and health
3. Some fundamental aspects of food protein hydrolysis
4. Scale-up of enzymatic peptide-synthesis in an enzyme membrane reactor
5. Protein quality of chickpea (Cicer arietinum L.) protein hydrolysates
6. The importance of peptide lengths in hypoallergenic infant formulae
7. Use of a peptide rather than a free amino acid nitrogen source in chemically defined elemental diet
8. Effect of peptide chain length on absorption of egg protein hydrolysates in the normal human jejunum
9. Glycyl dipeptides: New substrates for protein nutrition
10. Production of soluble enzymatic protein hydrolysate from industrially defatted nondehulled sunflower meal
11. Use of hydrolysates for protein supplementation
12. Small intestinal absorption of amino acids and a dipeptide in pancreatic insufficiency
13. Future of enteral nutrition
14. Diet formulation and choice of enteral diet
15. Enlarged-scale production of a low-phenylalanine peptide substance as a foodstuff for patients with phenylketonuria
16. Visceral protein levels in trauma patients are greater with peptide diet than with intact protein diet
17. The effect of normalization of plasma amino acids on hepatic encephalopathy in man
18. Separation of peptide groups with definite characteristics from enzymatic protein hydrolysate
19. Control of food allergies using protein hydrolysates
20. Development and production of hypoallergenic protein hydrolysates for use in infant formulas
21. Spices and seasonings: Hydrolyzed proteins
22. Vegetable protein hydrolysates
23. Chemical and enzymatic modification of food proteins
24. Enzymatic production of a low-phenylalanine product skim milk powder and caseinate
25. Enzymatic hydrolysis of casein: Effect of degree of hydrolysis on antigenicity and physical properties
26. Molecular mass distribution, immunological properties and nutritive value of whey protein hydrolysates
27. Hydrolysed cow's milk formulae allergenicity and use in treatment and prevention. An ESPACI position paper
28. Recent advances in enzymatic modifications of food proteins for improving their functional properties
29. Influence of enzymatic treatment on the nutritional and functional properties of pea flour
30. Isolated soy proteins
31. Production of extensive chickpea (Cicer arietinum L.) protein hydrolysates with reduced antigenic activity
32. Pea and fababean proteins
33. Peptide characteristics of sunflower protein hydrolysates
34. Partially hydrolyzed rapeseed protein isolates with improved functional properties
35. Characterization of enzymatic sunflower protein hydrolysates
36. Removing bitterness from protein hydrolysates
37. Treatment of phenylalanine hydroxylase deficiency
38. Nutrition in phenylketonuria
39. Responses of children with phenyl-ketonuria to dietary treatment
40. Disorders of amino acid metabolism, organic acidaemias, urea cycle defect
41. Molecular basis of phenylketonuria and a correlation between genotype and phenotype in a heterogeneous South-Eastern US population
42. New approaches to the treatment of phenylketonuria
43. Amino acid composition of food products used in the treatment of patients with disorders of the amino acid and protein metabolism
44. Treatment of Children with Phenylketonuria Using a Phenylalanine-Free Protein Hydrolysate (Albumaid XP)
45. Nutrient intake and growth of infants with phenylketonuria undergoing therapy
46. Debittering and nutritional upgrading of enzymic casein hydrolysates
47. Phenylalanine depletion for the management of phenylketonuria: Use of enzyme reactors with immobilized enzymes
48. Nutrient Intake of Treated Infants with Phenylketonuria
49. Allergic reactions to raw, pasteurized and homogenized/pasteurized cow milk: A comparison. A double-blind placebo-controlled study in milk allergy children
50. Immunogenicity evaluation of protein hydrolysates for hypoallergenic infant formulas
51. Use of hydrolysate-based products in special medical diets
52. Allergenicity of milk protein hydrolysates formulae in children with cow's milk substitutes
53. Reduction in the antigenicity of whey proteins by heat treatment: A possible strategy for producing a hypoallergenic infant formula
54. Food processing approaches to altering allergenic potential of milk-based formula
55. Whey protein allergenicity and its reduction by technological means
56. Characterization of antigens and allergens in hypoallergenic formulae
57. Antigenicity of whey protein hydrolysates fractionated with ultrafiltration membrane
58. Allergenic and antigenic activity of peptide fragments in a whey hydrolysate formula
59. Processing and evaluation of protein hydrolysates
60. Hypoallergenic infant formulas
61. IgE antibodies to hydrolysate of cow milk proteins in children with cow milk allergy
62. Anaphylactic reactions to a cow's milk whey protein hydrolysate (Alfa-Re, Nestle) in infants with cow's milk allergy
63. Serum specific-IgE antibodies to peptides detected in a casein hydrolysate formula
64. Nutrition in liver disease
65. Plasma amino acid patterns in liver disease
66. Nutrients in the pathogenesis and treatment of hepatic encephalopathy
67. The role of plasma amino acids in hepatic encephalopathy
68. Beneficial effects of aggressive protein feeding in severely burned children
69. Nutritional treatment of liver cirrhosis by branched-chain amino acids-enriched nutrient mixture
70. The BCAA/AAA ratio of plasma amino acids in three different groups of cirrhotics
71. Nutritional support in hepatic encephalopathy
72. Branched-chain-enriched amino acid solutions in patients with liver failure: An early example of nutritional pharmacology
73. Use of branched amino acids for treating hepatic encephalopathy: Clinical experiences
74. Disease-specific amino acid infusion (F080) in hepatic encephalopathy: A prospective, randomized, double-blind, controlled trial
75. Cirrhosis, encephalopathy, and improved results with metabolic support
76. Enzymatic modification of zein to produce an non-bitter peptide fraction with a very high fisher ratio for patients with hepatic encephalopathy
77. Low molecular weight sunflower protein hydrolysate with low concentration in aromatic amino acids
78. Sunflower protein hydrolysates for dietary treatment of patients with liver failure